254 related articles for article (PubMed ID: 31068063)
1. Remote neuropsychological assessment of elderly Japanese population using the Alzheimer's Disease Assessment Scale: A validation study.
Yoshida K; Yamaoka Y; Eguchi Y; Sato D; Iiboshi K; Kishimoto M; Mimura M; Kishimoto T
J Telemed Telecare; 2020; 26(7-8):482-487. PubMed ID: 31068063
[TBL] [Abstract][Full Text] [Related]
2. A Validation Study of the Remotely Administered Montreal Cognitive Assessment Tool in the Elderly Japanese Population.
Iiboshi K; Yoshida K; Yamaoka Y; Eguchi Y; Sato D; Kishimoto M; Funaki K; Mimura M; Kishimoto T
Telemed J E Health; 2020 Jul; 26(7):920-928. PubMed ID: 31746697
[No Abstract] [Full Text] [Related]
3. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
Nogueira J; Freitas S; Duro D; Almeida J; Santana I
Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
[TBL] [Abstract][Full Text] [Related]
4. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
Papp E; Pákáski M; Drótos G; Kálmán J
Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
[TBL] [Abstract][Full Text] [Related]
5. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
Wessels AM; Dowsett SA; Sims JR
J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
[TBL] [Abstract][Full Text] [Related]
6. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
Zainal NH; Silva E; Lim LL; Kandiah N
Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
8. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
[TBL] [Abstract][Full Text] [Related]
9. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
[TBL] [Abstract][Full Text] [Related]
10. The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.
Skinner J; Carvalho JO; Potter GG; Thames A; Zelinski E; Crane PK; Gibbons LE;
Brain Imaging Behav; 2012 Dec; 6(4):489-501. PubMed ID: 22614326
[TBL] [Abstract][Full Text] [Related]
11. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
[TBL] [Abstract][Full Text] [Related]
12. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan.
Wei YC; Chen CK; Lin C; Chen PY; Hsu PC; Lin CP; Shyu YC; Huang WY
Dement Geriatr Cogn Disord; 2022; 51(4):365-376. PubMed ID: 35820405
[TBL] [Abstract][Full Text] [Related]
13. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
14. Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer's disease.
Ulbl J; Rakusa M
Acta Neurol Belg; 2022 Jun; 122(3):695-702. PubMed ID: 34424494
[TBL] [Abstract][Full Text] [Related]
15. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
16. Examining the reliability of ADAS-Cog change scores.
Grochowalski JH; Liu Y; Siedlecki KL
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
[TBL] [Abstract][Full Text] [Related]
17. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
[TBL] [Abstract][Full Text] [Related]
18. Reliability and concurrent validity of Alzheimer's disease assessment scale - Cognitive subscale, Chinese version (ADAS-Cog-C) among Chinese community-dwelling older people population.
Jiang Y; Yang H; Zhao J; Wu Y; Zhou X; Cheng Z
Clin Neuropsychol; 2020 Dec; 34(sup1):43-53. PubMed ID: 32279575
[TBL] [Abstract][Full Text] [Related]
19. The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.
Chu LW; Chiu KC; Hui SL; Yu GK; Tsui WJ; Lee PW
Ann Acad Med Singap; 2000 Jul; 29(4):474-85. PubMed ID: 11056778
[TBL] [Abstract][Full Text] [Related]
20. Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.
Wang X; Li F; Tian J; Gao Q; Zhu H
Eur J Med Res; 2023 Oct; 28(1):427. PubMed ID: 37821912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
